EUS-guided fiducial placement before targeted radiation therapy for prostate cancer

Gastrointestinal Endoscopy

Volumn 70, Issue 3, 2009, Pages 579-583

  Yang, Julie ^a   Abdel Wahab, May ^a   Ribeiro, Afonso ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; ENDOSCOPIC ECHOGRAPHY; FEASIBILITY STUDY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTESTINE PREPARATION; MALE; PATIENT SAFETY; PRIORITY JOURNAL; PROSTATE CANCER; RETROSPECTIVE STUDY; TERTIARY HEALTH CARE;

AGED; AGED, 80 AND OVER; BRACHYTHERAPY; DOSE-RESPONSE RELATIONSHIP, RADIATION; ENDOSONOGRAPHY; FEASIBILITY STUDIES; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 68949146885     PISSN: 00165107     EISSN: 10976779     Source Type: Journal    
DOI: 10.1016/j.gie.2009.03.001     Document Type: Article

References (15)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2008. CA Cancer J Clin 58 (2008) 71-96
2. Langenhuijsen J.F., van Lin E.N., Kiemeney L.A., et al. Ultrasound-guided transrectal implantation of gold markers for prostate localization during external beam radiotherapy: complication rate and risk factors. Int J Radiat Oncol Biol Phys 69 (2007) 671-676
3. Shinohara K., and Roach III M. Technique for implantation of fiducial markers in the prostate. Urology 71 (2008) 196-200
4. Dehnad H., Nederveen A.J., van der Heide U.A., et al. Clinical feasibility study for the use of implanted gold seeds in the prostate as reliable positioning markers during megavoltage irradiation. Radiother Oncol 67 (2003) 295-302
5. American Society for Gastrointestinal Endoscopy. Guideline on the management of anticoagulation and antiplatelet therapy for endoscopic procedures. Gastrointest Endosc 55 (2002) 775-779
6. Peeters S.T., Heemsbergen W.D., Koper P.C., et al. Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. J Clin Oncol 24 (2006) 1990-1996
7. Pollack A., Zagars G.K., Starkschall G., et al. Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 53 (2002) 1097-1105
8. Zietman A.L., DeSilvio M.L., Slater J.D., et al. Comparison of conventional-dose vs. high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. JAMA 294 (2005) 1233-1239
9. Lips I.M., Dehnad H., van Gils C.H., et al. High-dose intensity-modulated radiotherapy for prostate cancer using daily fiducial marker-based position verification: acute and late toxicity in 331 patients. Radiat Oncol 3 (2008) 15
10. Lips I., Dehnad H., Kruger A.B., et al. Health-related quality of life in patients with locally advanced prostate cancer after 76 Gy intensity-modulated radiotherapy vs. 70 Gy conformal radiotherapy in a prospective and longitudinal study. Int J Radiat Oncol Biol Phys 69 (2007) 656-661
11. Scarbrough T.J., Golden N.M., Ting J.Y., et al. Comparison of ultrasound and implanted seed marker prostate localization methods: Implications for image-guided radiotherapy. Int J Radiat Oncol Biol Phys 65 (2006) 378-387
12. Kupelian P.A., Langen K.M., Willoughby T.R., et al. Image-guided radiotherapy for localized prostate cancer: treating a moving target. Semin Radiat Oncol 18 (2008) 58-66
13. McGahan J.P., Ryu J., and Fogata M. Ultrasound probe pressure as a source of error in prostate localization for external beam radiotherapy. Int J Radiat Oncol Biol Phys 60 (2004) 788-793
14. Van der Heide U.A., Kotte A.N., Dehnad H., et al. Analysis of fiducial marker-based position verification in the external beam radiotherapy of patients with prostate cancer. Radiother Oncol 82 (2007) 38-45
15. Pishvaian A.C., Collins B., Gagnon G., et al. EUS-guided fiducial placement for CyberKnife radiotherapy of mediastinal and abdominal malignancies. Gastrointest Endosc 64 (2006) 412-417